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Abstract
Purpose—As epidemiological studies expand to examine gene–environment interaction effects, 
it is important to identify factors associated with participation in genetic studies. The National 
Birth Defects Prevention Study is a multisite case–control study designed to investigate 
environmental and genetic risk factors for major birth defects. The National Birth Defects 
Prevention Study includes maternal telephone interviews and mailed buccal cell self-collection 
kits. Because subjects can participate in the interview, independent of buccal cell collection, 
detailed analysis of factors associated with participation in buccal cell collection was possible.
Methods—Multivariable logistic regression models were used to identify the factors associated 
with participation in the genetic component of the study.
Results—Buccal cell participation rates varied by race/ethnicity (non-Hispanic whites, 66.9%; 
Hispanics, 60.4%; and non-Hispanic blacks, 47.3%) and study site (50.2–74.2%). Additional 
monetary incentive following return of buccal cell kit and shorter interval between infant’s 
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estimated date of delivery and interview were associated with increased participation across all 
racial/ethnic groups. Higher education and delivering an infant with a birth defect were associated 
with increased participation among non-Hispanic whites and Hispanics.
Conclusion—Factors associated with participation varied by race/ethnicity. Improved 
understanding of factors associated with participation may facilitate strategies to increase 
participation, thereby improving generalizability of study findings.
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INTRODUCTION
Understanding the contribution of genetic variants and gene–environment interactions to 
disease susceptibility and treatment response has the potential to enhance medical treatments 
and public health interventions. As technologies advance, more epidemiological studies will 
have the capacity to investigate genetic susceptibilities to environmental exposures and 
diseases and may include the collection of a biological sample.1–3 Although follow-up 
measures can be applied to an epidemiological study to encourage participation, it is still not 
clear what characteristics may influence a subject’s decision to participate or not to 
participate in a study that includes the collection of biological specimens.4–9 Therefore, 
defining the differences between those who participate and those who do not participate will 
have important benefits for future epidemiological research. However, the inclusion of a 
genetic component might affect study participation and thereby causing selection bias due to 
concern about the risks of collecting genetic information.5,10–12 Differences between those 
who participate and those who do not participate can be used to predict characteristics that 
influence participation and can be used to develop strategies to increase participation rates in 
a genetic component of a study. Furthermore, the potential biases that arise as a result of low 
participation rates can also be better evaluated.4 The few previous studies that have 
investigated differences between participants who provided biological samples and those 
who declined to do so6,8,13,14 demonstrated that race/ethnicity, age, health status, education, 
and other demographic factors are associated with participation.8,9,14–17 A previous analysis 
of buccal cell participation at 1 of 10 study sites of the National Birth Defects Prevention 
Study (NBDPS) found that non-Hispanic white race, higher maternal education, and the 
addition of monetary incentives were associated with higher participation in buccal cell 
collection.14
Our objective was to determine what factors were associated with participation in buccal cell 
collection of the NBDPS, an ongoing population-based case–control study of risk factors for 
major birth defects across nine study sites. In a 1 hour NBDPS telephone interview study, 
personnel obtained information on the mother’s demographic characteristics, lifestyle, and 
health behaviors. The NBDPS requires self-collection of DNA through the completion and 
return of a buccal cell collection kit with a written consent. This staged consent allows for 
detailed analysis to determine if demographic characteristics, lifestyle, and health behaviors 
of the individuals who participated in the interview are associated with participation in 
buccal cell collection. Better understanding of factors potentially associated with 
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participation could facilitate strategies to increase participation, thereby improving 
generalizability of study findings.
MATERIALS AND METHODS
The NBDPS is an ongoing, population-based, case–control study based on birth defects 
surveillance systems within specified geographic areas in Arkansas, California, Georgia, 
Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah. One of the 
10 NBDPS sites (New Jersey) was excluded from this analysis as they participated in the 
study for a limited time period (1997–2002). The NBDPS is a multisite case–control study 
designed to investigate environmental and genetic risk factors for major birth defects. Case 
infants are identified from each state’s birth defects surveillance system and have one or 
more of over 30 eligible birth defects and include liveborn or stillborn infants and electively 
terminated fetuses. Mothers can be excluded from the NBDPS due to social reasons (child in 
foster care, adoption). Controls are unaffected liveborn infants randomly selected from the 
same base population as case infants using either birth certificates or birth hospitals delivery 
logs.18 Following initial identification and medical record abstraction, medical information 
is reviewed by clinical geneticists. Eligible case and control mothers are mailed an 
introductory letter, a fact sheet about the NBDPS, and a $20 incentive (check or money 
order) which the mother is advised she can keep, regardless of whether or not she chooses to 
participate in the NBDPS. This packet, available in English and Spanish, is mailed to the 
mother not earlier than 6 weeks after her infant’s estimated date of delivery (EDD). Mothers 
are then contacted via telephone by trained interviewers, who described the NBDPS 
according to a standardized script and asked the mother for her verbal consent to participate 
in the interview. Mothers are interviewed using a computer-assisted telephone interview 
from 6 weeks to 24 months after the EDD.18 Interviews are completed in English or 
Spanish, according to the preference of the mother. At the end of the interview, the mother is 
informed that a buccal cell collection kit will be sent to her address. The kit contains: a 
letter, collection instructions, three color-coded envelopes each containing two brushes for 
the mother, father, and infant; a consent form; and a second $20 incentive. After receiving 
the kit, the mother decides whether or not to participate in buccal cell collection and is again 
informed that the $20 can be kept regardless of whether she chooses to participate. A mother 
receives up to two reminder calls and three reminder letters asking if she has any questions 
and encouraging her to return buccal cell samples. Mothers were only eligible to participate 
in buccal cell collection if they completed the telephone interview. Nonparticipants were not 
asked to indicate why they would not participate in buccal cell collection. To increase 
participation in the NBDPS, incentive strategies changed over time with varying dates of 
implementation at each NBDPS study site. For the current analysis, incentive strategies that 
were compared were: (i) $20 incentive with invitation to interview and $20 incentive with 
buccal cell collection kit and (ii) $20 incentive with invitation to interview, $20 incentive 
with buccal cell collection kit, and an additional $20 incentive after return of completed 
buccal cell samples. One of the NBDPS sites (site 9) implemented incentive packages one 
and two (as above) simultaneously. Therefore, site 9 was excluded from analyses that 
assessed monetary incentives.
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Our analyses were limited to mothers who completed the interview and therefore were 
eligible for buccal cell collection. Sociodemographic and health characteristics among 
mothers who provided buccal cell samples were compared with those who did not. Buccal 
cell sample participation was defined as return of any of the buccal brushes and a signed 
consent form. Nonparticipants included both those who actively declined participation 
(provided an explicit refusal statement) and those who did not return the kit (passive 
refusals). Because the dates of implementation of buccal cell collection varied by NBDPS 
site, this analysis was limited to subjects with an EDD after the date that buccal cell 
collection was added to the local study protocol.
Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using manual 
backward multiple logistic regression to identify factors potentially associated with 
participation in buccal cell collection. The Hosmer–Lemeshow test was used to assess 
goodness of fit. Nonsignificant factors were eliminated unless there was a reduction in the fit 
of the model.
The factors that were assessed were grouped into four categories: modifiable study design 
characteristics, demographic characteristics, pregnancy/infant characteristics, and lifestyle 
characteristics. Variables were dichotomized to minimize the number of degrees of freedom 
in the statistical models, and to be consistent with other published analyses, if possible. Most 
of the cut points are used consistently in NBDPS analyses and are based on how the 
question is asked ($50,000 cut point) or convention (<37 vs. ≥37 weeks). The modifiable 
study design characteristics included: receipt of the third $20 incentive after buccal cell 
sample participation versus receipt of two monetary incentives ($20 incentive with invitation 
to interview and $20 incentive with buccal cell collection kit), time between baby’s EDD 
and maternal interview (<12 vs. ≥12 months), and language of interview (English versus 
Spanish) among Hispanic mothers). The demographic characteristics included: NBDPS site 
(study site 7 referent), maternal age (≥25 vs. <25 years), maternal race/ethnicity (non-
Hispanic white referent), maternal education (≥12 vs. <12 years), household income (≥
$50,000 vs. <$50,000), mother employed outside the home (yes versus no), and mother born 
in the United States (yes versus no). The pregnancy/infant characteristics included: case 
versus control infants, preterm delivery (<37 vs. ≥37 weeks), gravidity (primigravid versus 
multigravid), outcome of the pregnancy (fetal death/pregnancy termination versus live 
birth), and pregnancy intendedness (wanting to become pregnant at the time of conception 
and/or stopped using contraception versus not wanting to become pregnant or wanting to 
wait until later stages). The lifestyle characteristics included: use of folic acid/multivitamins 
(any use during the month before conception and the first month of pregnancy versus no use 
during this period), maternal drinking (any alcohol use from 3 months before pregnancy 
through the end of pregnancy—yes versus no), maternal smoking (any smoking from 3 
months before pregnancy through the end of pregnancy—yes versus no).
We also assessed patterns in participation over time. Calendar year was colinear with many 
of the covariates, and the overall participation rate for buccal cell collection rate varied over 
time; therefore, calendar year was not included in the statistical models.
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To address the strong correlation of race/ethnicity, NBDPS site, and monetary incentive, we 
performed a generalized estimating equation model analysis using study site as a repeated 
measure. The results of the generalized estimating equation model were similar to the 
manual backward logistic regression model; therefore, the results of the backward logistic 
regression model are presented in this paper.
As a subanalysis, among families with a liveborn infant, multivariable logistic regression 
was used to assess the association between buccal cell participation and case/control status. 
The phenotypes that were assessed were selected a priori based on the level of severity and 
potential hesitancy of collection of an oral buccal cell sample. The following isolated 
defects/defect groups were assessed: spina bifida, eye defects (anophthalmos/
microphthalmos, glaucoma/anterior chamber defects, and cataracts), anotia/microtia, heart 
defects, critical congenital heart defects (hypoplastic left heart syndrome, pulmonary atresia 
(with intact septum), transposition of the great arteries, truncus arteriosus, tricuspid atresia, 
tetralogy of Fallot, and total anomalous pulmonary venous return), any orofacial cleft, cleft 
lip with cleft palate, cleft lip without cleft palate, cleft palate alone, esophageal atresia, 
hypospadias, any limb deficiency, and gastroschisis. In addition, to assess if participation in 
buccal cell collection varied by phenotype, we also compared participation of case infants 
with isolated defects affecting the mouth (any orofacial cleft, cleft lip with cleft palate, cleft 
lip without cleft palate, and cleft palate) to case infants with isolated limb deficiencies. 
Estimates of associations were adjusted for preterm delivery, NBDPS study site, maternal 
race/ethnicity, education, folic acid use, drinking, smoking, pregnancy intendedness, 
provision of an additional $20 incentive, and time interval from EDD to telephone interview.
All statistical analyses were performed using SAS 9.3 (SAS Institute, Cary, NC).
RESULTS
Among mothers who were eligible to complete the NBDPS interview, the overall interview 
participation rate was 64.8% among cases and 64.7% among controls. The overall interview 
participation rate was highest among Non-Hispanic whites (68.9%), followed by Hispanics 
(60.3%) and non-Hispanic blacks (59.2%) (Table 1).
A total of 26,715 mothers who completed the telephone interview were eligible to receive a 
buccal cell collection kit (19,710 cases and 7,005 controls). Buccal cell sample collection 
was completed by 62.9% of the interviewed mothers (Figure 1). Participation rates were 
highest at study site 6 (74.2%) and lowest at site 2 (50.2%). Participation rates were highest 
among non-Hispanic whites (67.2%), followed by Hispanics (60.2%) and non-Hispanic 
blacks (46.6%) (Table 1).
Crude ORs showed that modifiable study design characteristics, demographic 
characteristics, pregnancy/infant characteristics, and lifestyle characteristics were associated 
with changes in participation in buccal cell collection (Table 2; Supplementary Table S1 
online). NBDPS site and maternal race/ethnicity were strongly associated with participation 
in buccal cell collection as well as with many of the factors that were assessed; therefore, 
further analyses were stratified by site and maternal race/ethnicity.
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Modifiable study design characteristics
Associations with modifiable study design characteristics and buccal cell collection did not 
vary by race/ethnicity and varied only slightly by NBDPS site (Table 3; Supplementary 
Tables S2–S5 online). Combining all race/ethnicities, participation increased with the 
receipt of an additional $20 incentive after the return of buccal cell samples (adjusted OR 
(aOR) = 1.52; 95% CI = 1.42, 1.62); six of the eight NBDPS sites showed statistically 
significant increases in participation with the extra incentive. Similarly, participation in 
buccal cell collection increased among mothers of all race/ethnicities (aOR = 1.32; 95% CI 
= 1.24, 1.40) when the woman was interviewed within 12 months; for seven of the nine 
study sites, participation was statistically significantly higher (Supplementary Table S2 
online).
Demographic characteristics
Associations of demographic characteristics and participation in buccal cell collection 
remained consistent across race/ethnic groups and NBDPS sites (Table 3; Supplementary 
Tables S2–S5 online). Non-Hispanic black mothers (aOR = 0.47; 95% CI = 0.42, 0.52) and 
Hispanic mothers (aOR = 0.71; 95% CI = 0.65, 0.78) were less likely to participate in buccal 
cell collection compared with non-Hispanic white mothers. Overall, maternal education ≥12 
years was associated with an increase in participation (aOR = 1.21; 95% CI = 1.14, 1.29); 
results were similar between non-Hispanic white and Hispanic mothers, but for non-
Hispanic black mothers, no significant association was found between maternal education 
and participation. Overall, mothers born in the United States were less likely to participate in 
buccal cell collection (aOR = 0.89; 95% CI = 0.82, 0.96) compared with those born 
elsewhere. When stratified by race/ethnicity, Hispanic mothers that were born in the United 
States were less likely to participate in buccal cell collection (aOR = 0.72; 95% CI = 0.64, 
0.81) than Hispanic mothers that were not born in the United States (Table 3). No significant 
association in buccal cell participation was found among non-Hispanic white and non-
Hispanic black mothers born in the United States versus elsewhere. The lack of a significant 
finding may be due to small sample size within the subgroups.
Pregnancy/infant characteristics
Associations between pregnancy/infant characteristics and participation in buccal cell 
collection did not vary by NBDPS site or by race/ethnicity (Table 3; Supplementary Tables 
S2–S5 online). Mothers of case infants were more likely to participate in buccal cell 
collection than mothers of control infants (aOR = 1.37; 95% CI = 1.29, 1.46) (Table 3).
Lifestyle characteristics
Associations between lifestyle characteristics and buccal participation varied by race/
ethnicity and by NBDPS site (Table 3; Supplementary Tables S2–S5 online). Overall, 
mothers who used folic acid or multivitamins at any time in the month before pregnancy or 
the first month of pregnancy were more likely to participate than those who did not use folic 
acid or multivitamins. Overall, mothers who consumed alcohol at any point during 
pregnancy were more likely to participate than those who did not consume alcohol (aOR = 
1.10; 95% CI = 1.03, 1.16) (Table 3); this finding was consistent among all sites except site 
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8, where maternal drinking was found to have a decreased association with buccal cell 
collection (aOR = 0.73; 95% CI = 0.59, 0.91) (Supplementary Table S2 online). Mothers 
who smoked during pregnancy were less likely to participate (aOR = 0.83; 95% CI = 0.77, 
0.89) (Table 3); findings were reversed for site 3 (aOR = 1.23; 95% CI = 1.01, 1.51) 
(Supplementary Table S2 online).
Types of defects
As a subanalysis, we examined participation in buccal cell collection by phenotype. Among 
mothers of children with selected isolated birth defects, non-Hispanic white and Hispanic 
mothers were more likely to participate than non-Hispanic black mothers. Non-Hispanic 
black mothers of infants with critical congenital heart defects were more likely to participate 
than non-Hispanic white and Hispanic mothers (Table 4). The association between 
participation in buccal cell collection by case/control status did not vary by birth defect 
phenotype. Similarly, participation among families affected by orofacial clefts was similar to 
that among families affected by isolated limb deficiencies.
DISCUSSION
Among women enrolled in the NBDPS, provision of buccal cell samples was associated 
with several demographic and study-specific characteristics. Race/ethnicity was strongly 
associated with participation in buccal cell collection; non Hispanic black and Hispanic 
mothers had lower participation rates than non-Hispanic white mothers. The association of 
race/ethnicity with participation in buccal cell collection was consistent with recent findings 
of other studies.14,19,20 Our expanded analysis produced findings consistent with a 2006 
paper on participation in buccal cell collection at the Atlanta NBDPS site including data 
from 1999 to 2002.14 This study found that non-Hispanic black mothers had lower 
participation rates than non-Hispanic white and Hispanic mothers.14 In the 1999–2000 
National Health and Nutrition Examination Survey, non-Hispanic blacks were less likely to 
consent to have a blood sample saved for genetic research than non-Hispanic whites and 
Mexican Americans.15 In the 2003–2004 National Health and Nutrition Examination 
Survey, when the item mentioning about the date of DNA collection was removed from the 
continuing studies consent document, there was no longer a significant decrease in consent 
by non-Hispanic blacks, and racial/ethnic differences were no longer observed.21 A number 
of studies have indicated a lower level of trust of medical research among the African–
American population in comparison with other racial/ethnic groups.22–24
Our data suggest that participation in buccal cell collection is affected by several 
characteristics. Across all race/ethnicities, the addition of a $20 incentive after the return of 
the buccal cell samples increased participation, with participation of non-Hispanic black 
mothers considerably improved by the additional incentive. This finding is consistent with 
previous studies that have shown that monetary incentives improve study participation 
rates.14,19,20 We also found participation increased when the time from EDD to telephone 
interview was <12 months. Although each NBDPS site has varying protocols for data 
abstraction, case ascertainment, medical record review by a clinical geneticist, and maternal 
contact, the time from EDD to telephone interview is comparable across sites.
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Case mothers were more likely to participate in buccal cell collection than control mothers. 
This could indicate that mothers with an infant with a health problem are more likely to 
participate in research than those without. This finding is consistent with a recent study on 
participation in cancer genetics research, where those who had a first-degree relative with 
cancer were significantly more likely to provide a blood specimen for DNA analysis (OR = 
1.57; P = 0.005).25
Our findings suggested that mothers with positive health behaviors were more likely to 
participate in buccal cell collection than mothers with negative health behaviors. Mothers 
who took folic acid or multivitamin supplements during the month before pregnancy or the 
first month of pregnancy were more likely to participate, whereas those mothers who 
smoked during pregnancy were less likely to participate. These findings are consistent with 
another study which found that subjects with favorable lifestyle factors such as regular 
exercise, nonsmokers, and nondrinkers were more likely to participate in buccal cell 
collection.8 We did find, however, that overall and in Hispanic mothers, those who 
consumed alcohol were more likely to participate in buccal cell collection. It is hypothesized 
that consumption of alcohol could be an indicator of higher socioeconomic status. A recent 
study showed that pregnant women who reported any alcohol use during pregnancy were 
more likely to be employed and have a college degree.26 Previous studies have shown that 
higher income individuals are more likely to participate in genetic research than those with 
lower income.16,17 In our data, mothers with household income ≥$50,000 were more likely 
to participate in buccal cell collection at two of the nine study sites than those with 
household income <$50,000 per year.
One of the strengths of this study is enrollment of a large, diverse population-based sample 
enabling comparisons by race/ethnicity, and geographic regions. Cases and controls were 
enrolled from the same base population. A recent study found that control participants in the 
NBDPS generally are representative of their base populations.27 An additional strength is 
that participants were interviewed before the buccal cell kits were mailed and thus had an 
opportunity to consent separately to the two different components of the study. We were 
therefore able to analyze data on many characteristics provided by the participant in the 
telephone interview enabling us to characterize nonparticipants.
Some limitations of this study were that nonparticipants included those that both actively 
(provided an explicit refusal statement) and passively refused (did not return the buccal cell 
collection kit, with no reason given). A recent study assessed attitudes regarding DNA 
collection in the NBDPS through focus groups of mothers who had participated in the 
buccal cell component of the study and those who had not.12 The primary reasons focus 
group respondents would choose not to participate in buccal cell collection included distrust 
of the government, concerns or skepticism regarding how DNA specimens and genetic 
information would be used, and paternal skeptism about sharing specimens and genetic 
information.12 The primary reasons focus group respondents would choose to participate in 
buccal cell collection included wanting to help prevent or find cures for birth defects, to help 
advance science in general, or both.
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We considered time interval between EDD and the maternal interview a modifiable study 
characteristic. However, in some instances, the time interval from the EDD to interview is 
dependent on phenotype and other external factors not under the control of study staff. Some 
phenotypes do not present until later and/or require lengthy hospitalizations delaying the 
time between the EDD and the time the neonatal or infant discharge record is available for 
case identification. Data from three of the nine sites were not stratified by race/ethnicity due 
to the small sample size of non-Hispanic black mothers at those sites. It was not possible to 
determine why the participation rate varied by study center. We believe that demographic 
differences account for the variance in participation. Given that the study population is 
women who were recently pregnant, we are unsure if the results are generalizable to the 
average epidemiological research population. However, as data are generally collected 6 
months after pregnancy, this may not be a substantially limiting factor.
For researchers conducting genetic epidemiological studies, it is encouraging that some 
modifiable study characteristics were associated with increased participation. Other 
variables associated with participation had less to do with field operations. Participation 
among non-Hispanic whites was substantially higher than other racial-ethnic groups. Lower 
participation among other racial-ethnic groups could limit the generalizability of study 
findings and adversely affect statistical power. We suggest the researchers to utilize 
evidence from our study and others to develop strategies and protocols to target those groups 
less likely to participate in the genetic component of the study, and to invest in outreach to 
understand hesitancies and concerns.
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Figure 1. National Birth Defects Prevention Study: rates of participation in interview and buccal 
cell collection, 1997–2007
1Centers did not start sending buccal collection kits until October 1999, more than 18 
months after the start of the interviews.
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Table 2
National Birth Defects Prevention Study: association between participation in buccal cell collection and 
covariates, 1997–2007 (crude ORs and 95% CIs)
Variable Responders/total % OR 95% CI
Total 16,794/26,715 62.9
Additional $20 after return of the completed kit—yesa 5,136/7,863 65.3 1.15 1.09, 1.22
Additional $20 after return of the completed kit—noa 10,093/16,252 62.1
Time to interview <12 months 11,039/17,284 63.9 1.13 1.07, 1.19
Time to interview ≥12 months 5,755/9,431 61.0
English interview among Hispanics 2,505/4,226 59.3 0.89 0.81, 0.99
Spanish interview among Hispanics 1,405/2,268 61.9
Maternal race/ethnicity
 Non-Hispanic white 10,564/15,710 67.2 Ref
 Non-Hispanic black 1,266/2,714 46.6 0.43 0.39, 0.46
 Hispanic 3,910/6,494 60.2 0.74 0.69, 0.78
 Other 1,054/1,797 58.7 0.69 0.63, 0.76
Study site
 Study site 1 2,183/3,447 63.3 0.65 0.59, 0.72
 Study site 2 1,661/3,306 50.2 0.38 0.34, 0.42
 Study site 3 2,222/3,595 61.8 0.61 0.55,0.67
 Study site 4 1,747/3,257 53.6 0.44 0.39, 0.48
 Study site 5 1,069/1,997 53.5 0.43 0.39, 0.49
 Study site 6 2,289/3,086 74.2 1.08 0.97, 1.20
 Study site 7 2,745/3,778 72.6 Ref
 Study site 8 1,710/2,449 69.8 0.87 0.78, 0.97
 Study site 9 1,168/1,800 64.9 0.70 0.62, 0.79
Maternal age ≥25 11,057/17,432 63.4 1.07 1.02, 1.13
Maternal age <25 5,737/9,283 61.8
Maternal education ≥12 years 9,748/14,953 61.2 1.25 1.19, 1.31
Maternal education <12 years 7,037/11,737 60.0
Household income ≥$50, 000/year 5,228/8,137 64.2 1.09 1.03, 1.15
Household income <$50, 000/year 11,306/18,144 62.3
Mother born in the United States 13,609/21,393 63.6 1.17 1.10, 1.25
Mother not born in the United States 3,179/5,312 59.8
Child with birth defect (case) 12,679/19,710 64.3 1.27 1.20, 1.34
Child without birth defect (control) 4,115/7,005 58.7
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Variable Responders/total % OR 95% CI
Preterm delivery <37 weeks 3,833/6,162 62.2 0.97 0.91, 1.03
Term delivery ≥37 weeks 12,828/20,380 62.9
Fetal death, pregnancy terminationb 575/814 70.6 1.35 1.16, 1.57
Live birth 12,096/18,885 62.6
Primigravid 5,178/8,080 64.1 1.08 1.02, 1.14
Multigravid 11,614/18,632 62.3
Mother worked during pregnancy 11,975/18,924 65.5 1.06 1.00, 1.12
Mother did not work during pregnancy 4,815/7,777 61.9
Folic acid/multivitamin usec 8,857/13,442 65.9 1.30 1.24, 1.36
No folic acid/multivitamin use 7,937/13,273 59.8
Maternal drinkingd 7,432/11,691 63.6 1.06 1.00, 1.11
No maternal drinking 9,321/14,960 62.3
Maternal smokinge 3,427/5,624 60.9 0.90 0.85, 0.96
No maternal smoking 13,363/21,081 63.4
Intended pregnancy 10,084/15,637 64.5 1.18 1.12, 1.24
Unintended pregnancy 6,666/10,991 60.6
CI, confidence interval; OR, odds ratio; Ref, referent.
a




Any folic acid use during the month before conception and the first month of pregnancy versus no use during this period.
d
Any alcohol use from 3 months before pregnancy through the end of pregnancy—yes versus no.
e
Any smoking from 3 months before pregnancy through the end of pregnancy—yes versus no.
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